When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Apr 2025
Last updated: 23 Apr 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • definite IE per diagnostic criteria
  • fever/chills
  • cardiac murmur
  • night sweats, malaise, fatigue, anorexia, weight loss, myalgias
  • weakness
  • arthralgias
  • headache
  • shortness of breath
  • meningeal signs
  • Janeway lesions
  • Osler nodes
  • Roth spots

Other diagnostic factors

  • splinter haemorrhages
  • cutaneous infarcts
  • chest pain
  • back pain
  • palatal petechiae

Risk factors

  • prior history of infectious endocarditis
  • presence of artificial prosthetic heart valves
  • certain types of congenital heart disease
  • post-organ transplant (patients who develop a cardiac valvulopathy)
  • presence of cardiac implanted electronic device or intravascular catheters (e.g., for haemodialysis)
  • acquired degenerative valve disease
  • mitral valve prolapse (MVP) with valvular regurgitation
  • hypertrophic cardiomyopathy
  • intravenous drug use
  • chronic Q fever

Diagnostic investigations

1st investigations to order

  • blood cultures
  • echocardiography
  • full blood count
  • CRP
  • serum urea, electrolytes, and glucose
  • liver function tests
  • urinalysis
  • ECG

Investigations to consider

  • rheumatoid factor/other immunological blood tests
  • erythrocyte sedimentation rate
  • complement levels
  • computed tomography
  • magnetic resonance imaging
  • nuclear imaging and photon emission tomography (PET)

Treatment algorithm

Contributors

Expert advisers

Mamta Buch, MBChB, PhD, FRCP

Consultant Interventional Cardiologist

Manchester University NHS Foundation Trust

Manchester

UK

Disclosures

MHB has received speaker honoraria relating to transcatheter heart valve intervention: Medtronic, Edwards. Advisory board relating to transcatheter heart valve intervention: Abbott. MHB is Education Secretary for the British Heart Valve Society and member of the British Cardiovascular Intervention Society Structural Heart working group. MHB has faculty roles at national and international structural heart intervention meetings.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:

Tracey Keteepe-Arachi BSc (Hons), MBBS, MRCP (UK)

Cardiology Specialist Registrar and Clinical Research Fellow

Department of Cardiovascular Sciences

St George's Hospital Medical School

University of London

London

UK

Disclosures: TKA declares that she has no competing interests.

Aneil Malhotra MA (Hons), MSc, MB BChir, MRCP (UK)

Cardiology Specialist Registrar and Clinical Research Fellow

Department of Cardiovascular Sciences

St George's Hospital Medical School

University of London

London

UK

Disclosures: AM is an author of a number of references cited in this topic.

Michael Papadakis MD, MRCP (UK)

Clinical Lecturer in Cardiology

St George's University of London

London

UK

Disclosures: MP declares that he has no competing interests.

Peer reviewers

Bernard Prendergast, BMedSci, BM, BS, MD, FRCP, FESC

Professor of Interventional Cardiology and Valvular Heart Disease

St Thomas' Hospital

London

UK

Disclosures

BP declares that he has no competing interests.

Brian Angus, BSc MBChB, MD, FRCP

Professor

Oxford University

The John Radcliffe

Oxford

UK

Disclosures

BA declares he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042.Full text  Abstract

National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. July 2016 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer